Pulmonary Fibrosis News Forums Forums BioNews Content Flash Briefings & Podcasts FDA Granted Orphan Drug Status To Nitric Oxide As Potential IPF Treatment

  • FDA Granted Orphan Drug Status To Nitric Oxide As Potential IPF Treatment

    Posted by pulmonary-fibrosis-news-moderator on November 4, 2019 at 10:25 am

    Senior Director of Multichannel Content for Pulmonary Fibrosis News, Michael Morale, discusses how the FDA granted orphan drug status to nitric oxide as a potential IPF treatment.

    Are you interested in learning more about Pulmonary Fibrosis? If so, please visit pulmonaryfibrosisnews.com/

    What do you think about this news? Listen to this flash briefing episode and share your thoughts in the comment section below!

     

     

    Charlene Marshall replied 4 years, 3 months ago 3 Members · 2 Replies
  • 2 Replies

Log in to reply.